Figure 4. Effect of allicin at 60 days of follow-up on: Kidney damage markers.

Diuresis (A), proteinuria (B), microalbuminuria (C), and plasma creatinine (D). In kidney tissue; Nephrin expression (E) and KIM-1 expression (F). In urine; NGAL expression (G). For representative Western blotting, 3 randomly selected samples per group were analysed respectively. C, control; MS, metabolic syndrome; and MS+A, metabolic syndrome + allicin. Data are expressed as mean ± SEM and analysed by one-way ANOVA. Statistical significance was established as *p < 0.005 vs. C; ^#p < 0.05 vs. MS.